Avery Dennison Investor Presentation August 2014

Similar documents
Avery Dennison Corporate Profile

Morgan Stanley Conference. November 15, 2017

Praxair, Inc. Kelcey E. Hoyt Director, Investor Relations. Wells Fargo Industrial & Construction Conference May 08, 2014

AVERY DENNISON TO ACQUIRE PAXAR FOR $1.3 BILLION OR $30.50 PER SHARE

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

Presenter. Avery Dennison Corporation Date

Precision Engineered Products Acquisition August 17, 2015

Credit Suisse 5 th Annual Industrials Conference. Jim Lico President & CEO

WILLIAM BLAIR GROWTH STOCK CONFERENCE. June 14, 2017

Praxair, Inc. Steve Angel Chairman, President and Chief Executive Officer. Goldman Sachs Basic Materials Conference May 22, 2013

Fiscal 2018 Fourth Quarter Earnings Call April 10, 2019

Avery Dennison Corporate Profile

Praxair, Inc. Steve Angel Chairman, President and Chief Executive Officer. Goldman Sachs European Chemicals 2020 Vision Conference June 18, 2013

FORWARD LOOKING STATEMENTS

William Blair Growth Stock Conference. Jim Lico President & CEO

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

WESCO International. Dave Schulz, Senior Vice President and Chief Financial Officer Raymond James 39 th Annual Investors Conference, March 7, 2018

Background Information. Updated May

THE GLOBAL HOUSE OF PRESTIGE BEAUTY FABRIZIO FREDA PRESIDENT AND CEO THE ESTÉE LAUDER COMPANIES ANNUAL STOCKHOLDERS MEETING

21 st Annual Needham Growth Conference. January 15, 2019

Electrical Products Group Conference. Jim Lico President & CEO

The Future of Consumer Health Care

2014 First Quarter Business Review

AmerisourceBergen. J.P. Morgan Healthcare Conference. Steve Collis, Chairman, President & CEO Tim Guttman, EVP & CFO.

FY2015 Third Quarter Earnings Call

Rockwell Automation Company Overview August Copyright 2016 Rockwell Automation, Inc. All Rights Reserved.

Investor Presentation May NASDAQ:FWRD

Linde plc Investor Update

Baird 2018 Global Industrial Conference. Jim Lico President & CEO

CISCO SYSTEMS, INC. Q4 FY 2004 CONFERENCE CALL

West Pharmaceutical Services, Inc. J.P. Morgan Healthcare Conference. Eric M. Green, President & CEO January 9, 2019

IBM REPORTS 2011 SECOND-QUARTER RESULTS

INVESTOR MEETING / MARCH 9, 2010

Bemis Company, Inc. KeyBanc Capital Markets Basic Materials & Packaging Conference

CB&I Investor Presentation March 2017

ITT Inc. Connect & Control Technologies (CCT) Supplemental Financial Data 2016 & 2015

CISCO SYSTEMS, INC. Q4 FY 2005 CONFERENCE CALL

VeriFone Files Restated Reports

Investor Presentation

Stericycle, Inc. Q NASDAQ: SRCL

CHECKPOINT SYSTEMS, INC. INVESTOR PRESENTATION June 2013

Investor Presentation. January 12, 2017

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017

PerkinElmer Announces Financial Results for the First Quarter 2008

May 24, 2011 New York, NY

Logitech. July 24, 2013

Jefferies 2015 Global Healthcare Conference June 3, 2015

Full year 2014 results

Fiscal 2014 Q3 Earnings. Mark Donegan Chairman & CEO January 23, 2014

FORTUNE BRANDS HOME & SECURITY, INC. ADJUSTED PRO FORMA INFORMATION (In millions, except per share amounts) (Unaudited)

Investor Presentation October NASDAQ:FWRD

Background Information. Updated June

Belden Leading the Way to an Interconnected World

Fresenius Investor News

Mylan. Raymond James 40 th Annual Institutional Investors Conference March 05, 2019

Taylor Acquisition Overview. May 18, 2018

Key Points for Today

Health Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona

Investor and Analyst Day

Jefferies 2017 Global Healthcare Conference. June 7, 2017

Vishay Precision Group

Brady Corporation F 17 Annual Shareholders Meeting

MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016

Sidoti & Company Spring 2018 Conference. Greg Woods, President and CEO David S. Smith, CFO March 29, 2018

2014 Preliminary Results & Strategy Review Update March 12, 2015

M A Y MIFI NASDAQ

Trimble Inc. Berenberg Design Software Conference USA 2018 March 2018

Safe Harbor Statement & Non-GAAP Information

IBM 4Q 2016 Earnings. January 19, ibm.com/investor

CommerceHub Investor Presentation

Fresenius Investor News

Deluxe Corporation. Overview, Strategy and Financial Information. Second Quarter 2013

Investor Deck. May 2018

Forward-Looking Statements. Strong Business Model and Strategy. Earnings per Share. Sales ($ Millions) Sustainable and Dependable Performance

General Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End

Financial Discussion. James Kavanaugh Senior Vice President and Chief Financial Officer IBM

UBS Best of Americas Conference

Unlocking Our Growth Opportunity

Fresenius Investor News

Praxair, Inc. Scott Telesz Senior Vice President

Fortive s Digital Strategy Morgan Stanley Digital Day. Fortive Corporation

Avnet Presentation Raymond James 38 th Annual Institutional Investors Conference

Trimble Investor Presentation October 2017

Health Care Worldwide. Bank of America, 2007 Health Care Conference, May 30, 2007

Cott Corporation Non Deal Roadshow Citi Boston September 12, 2018

Focusing Our Portfolio & Utilizing Our Financial Strength

CONFERENCE CALL 2015 RESULTS. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY

UBS Paper and Packaging Conference Cape Town 27 September 2012

Stephens Fall Investment Conference

Performance for the Second Quarter ended September 30, 2010

March Company Description

2017 Overview. February 27, 2018

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019

Inge Thulin. Chairman of the Board, President and CEO. Bernstein Strategic Decisions Conference. June 1, 2017

A Leading Global Health Care Group

Investor Presentation. November 2016

Rockwell Automation Company Overview January 2017

TENNANT COMPANY. BAIRD CONFERENCE November 7, Tom Paulson SVP and CFO REINVENTING HOW THE WORLD CLEANS

Praxair, Inc. Scott Telesz Senior Vice President

Transcription:

Avery Dennison Investor Presentation August 2014 Unless otherwise indicated, the discussion of the company s results is focused on its continuing operations, and comparisons are to the same period in the prior year. 1 Avery Dennison Investor Presentation

Forward-Looking Statements Certain statements contained in this document are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; the financial condition and inventory strategies of customers; changes in customer order patterns; worldwide and local economic conditions; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; fluctuations in currency exchange rates and other risks associated with foreign operations; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; fluctuations in pension, insurance, and employee benefit costs; impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; changes in political conditions; impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors. We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impact of economic conditions on underlying demand for our products; (2) competitors' actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume. For a more detailed discussion of these and other factors, see Risk Factors and Management s Discussion and Analysis of Results of Operations and Financial Condition in our 2013 Form 10-K, filed on February 26, 2014 with the Securities and Exchange Commission and subsequent quarterly reports on Form 10-Q. The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law. Use of Non-GAAP Financial Measures This presentation contains certain non-gaap financial measures as defined by SEC rules. As required by these rules, we have defined, qualified, and reconciled these non-gaap financial measures to the most directly comparable GAAP financial measures, in the Appendix of this document.

Overview > Sustainable competitive advantages in two core businesses» Global reach, scale» Product breadth, technical expertise, innovation» Service, quality 2013 Sales by Segment and End Market RBIS 26% > #1 share positions worldwide > Premium pricing and above industry margins PSM 73% Vancive Medical Technologies 1% > Targeting double-digit adjusted EPS CAGR through 2018 > Strong, consistent FCF with solid balance sheet enabling significant return of cash to shareholders Industrial / Durable 17% Logistics & Shipping 17% Medical / Healthcare 5% Retail Apparel 22% Non-durable Consumer Goods 39% 2013 Net Sales (as reported) = $6.1 billion 3 Avery Dennison Investor Presentation

2013 Sales by End Market Emerging Markets ~30% Other* 5% Latin Eastern America Europe & 8% MENA Western 8% Asia U.S. Europe (ex-japan) 25% 29% 14% Asia 30% * Canada, Australia, South Africa, and Japan Eastern U.S. Europe 37% & MENA 9% Latin America 7% Other* 5% Western Europe 23% 4 Avery Dennison Investor Presentation

Pressure-Sensitive Materials (PSM) > Leading manufacturer of self-adhesive film and paper label material > Packaged goods end markets:» Home & Personal Care» Food & Beverage» Pharmaceutical FINANCIAL SNAPSHOT 2013 Sales $4.5 bil. Organic Sales Growth 4.7% Adjusted Operating Margin* 10.2% > Variable information end markets:» Shipping Labels» Bar Codes > 10,000+ printing company customers serving packaged goods and logistics companies around the globe > Large and growing addressable markets» 38% of segment sales in emerging markets * Excluding restructuring charges and other items 5 Avery Dennison Investor Presentation

Pressure-Sensitive Materials (PSM) > Our products enable:» Increased shelf appeal of consumer packaged goods» Maximized design options for a wide range of containers» Printing with a broad range of inks, resolutions and finishing techniques» Label application at high speed» High-impact fleet and architecture branding» Bonding solutions (tapes) with greater functionality and/or lower total applied cost Rigid Film Squeezable Film Coated Paper Thermal Paper Graphics & Tapes 6 Avery Dennison Investor Presentation

Industry leader in expanding market > Unmatched scale and global footprint» 2.5 times larger than nearest competitor» Local manufacturing and distribution across the globe > Industry-leading service, quality, and technical expertise > Innovation leader in the space» Significant benefits from manufacturing adhesives > Unique commercial relationships and market insights 7 Avery Dennison Investor Presentation

Retail Branding & Information Solutions (RBIS) FINANCIAL SNAPSHOT > Global leader (>5x nearest competitor) in branding & information solutions for apparel industry» Branding solutions: graphic tags, packaging, labeling, embellishments» Information solutions: inventory tracking & routing, loss prevention, price management, brand protection 2013 Sales $1.6 bil. Organic Sales Growth 4.9% Adjusted Operating Margin* 6.3% * Excluding restructuring charges and other items 8 Avery Dennison Investor Presentation

Key Drivers of Value Creation Market Segment Leadership Share growth within key highvalue segments Accelerate RFID Adoption» Mid-term growth projection of 20%+» 3-yr CAGR (2010-2013) ~40% Global Supply Chain Optimization Global leadership in integrated, end-to-end inventory & loss prevention solutions Faster, highly-flexible, capital efficient supply chain and manufacturing footprint Exterior Embellishment Share Gains Performance innovation & leading brand partnership 9 Avery Dennison Investor Presentation

Market Segment Strategy Segments RBIS Segment Share 08 13 Projected Segment Unit CAGR * RBIS Segment Share 13-18 * Key Growth Drivers Performance / Outdoor Athletic 2-4% Innovation Embellish/labels Global compliance & protection Sustainable solutions Innovation Premium Fashion 2-4% Creative packaging and labels Brand protection & consistency Global compliance Creativity Fast Fashion 2-4% Blended in-plant /Service Bureau Quick response products/solutions Global compliance/automation Speed Contemporary Fashion 1-3% Inventory visibility & accuracy Price management Global compliance/automation Simplification Value 0-2% Global Compliance Blended in-plant /Service Bureau Private brand development Cost * Internal assessment / plan 10 Avery Dennison Investor Presentation

Improving RBIS s Productivity / Asset Utilization Key Actions > Implemented hub and spoke structure > Plant closures > Sites repurposed to fast response units > Technology consolidations > Standardized org structures > Integrated supply chain > Lean manufacturing culture > Digital conversion» Increased digital printing capacity to 30%+ in 2013; ~60% increase since 2011» Targeting 50%+ digital printing capacity by 2015 ~1.4 mil Sq Ft Global Reduction 2009 o 58 Sites o 6.6 mil Sq Footage o 50 Mfg Sites 2013 o 48 Sites o 5.2 mil Sq Ft ( ~20%) o 39 Mfg / Fast Response Sites Sales per Sq Ft Reliability % $308 $202 09 13 53% $350+ 86.1 18 09 97.9 13 14% 99.0+ 18 11 Avery Dennison Investor Presentation

Portfolio Overview Long-Term Targets (2014 2018) 2013 SALES ORGANIC SALES GROWTH (5-YEAR CAGR) GAAP EBIT MARGIN ADJ.* EBIT MARGIN (BY 2018) PSM $4.5 bil. 4-5% 10-11% 10-11% RBIS $1.6 bil. 4-5% 9.5-10.5% 10-11% Vancive Medical Technologies $74 mil. 10%+ ~10% ~10% * Excluding restructuring charges and other items 12 Avery Dennison Investor Presentation

Targeting Continued Strong Progress Through 2018 Organic Sales Growth (CAGR (1) ) 4% 5% 2018 Operating Margin Adjusted (2) EPS Growth (CAGR (1) ) 2018 Return on Total Capital (ROTC) (3) Net Debt to EBITDA 9% 10% (up ~ 2 pts vs 2013 adj (2) ) 12% 15%+ 16%+ (up 4+ pts vs 2013) 1.7x to 2.0x (1) Reflects five-year compound annual growth rates, with 2013 as the base period (2) Excluding restructuring charges and other items (3) Net operating profit, excluding restructuring charges and other items, after taxes divided by average invested capital 13 Avery Dennison Investor Presentation

Capital discipline is a key contributor to value creation 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 Fixed Asset (Net PP&E) Turnover (1) 2009 2010 2011 2012 2013 Operational Working Capital % of Sales (2) 15% 12% 9% 6% 3% 0% 2009 2010 2011 2012 2013 3.0 2.5 2.0 1.5 1.0 0.5 0.0 Net Debt / Adj. EBITDA (3) 2009 2010 2011 2012 2013 Long-Term Target (annual average) Impact of Discontinued Operations (1) WholeCo annual net sales divided by 2-point average consolidated net PP&E for years 2009 through 2012; 2013 reflects continuing operations for both sales and net PP&E (2) WholeCo operational working capital at year-end divided by annualized fourth quarter net sales for years 2009 through 2012; 2013 reflects continuing operations for both operational working capital and net sales (3) Net Debt / LTM WholeCo Adj. EBITDA, 4-qtr Avg.; adj. EBITDA excludes restructuring charges and other items 14 Avery Dennison Investor Presentation

5-Year Capital Deployment ($ in millions) 2014-2018 Cumulative Capital Sources: Leverage Capacity (2013) ~ $350 Add'l Leverage Capacity (Organic EBITDA Growth) up to $700 Cash Flow from Ops before Restructuring $2,700 - $2,900 Available Capital $3,300 - $4,000 Capital Uses: % of Total Restructuring < $150 < 5% Capex ~ $1,000 25% - 30% Dividends ~ $750 ~ 20% Add'l Capital Available to Shareholders / M&A $1,400 - $2,000 ~ 50% Total Capital Available to Shareholders / M&A $2,150 - $2,750 ~ 70% 15 Avery Dennison Investor Presentation

2011 Avery Dennison Corporation. All rights reserved. Avery Dennison and all other Avery brands, product names and codes are trade marks of Avery Dennison Corporation. All other brands and product names are trademarks of their respective owners. Fortune 500 is a trademark of Time, Inc. Personal a nd company names and other information on samples depicted are fictitious. Any resemblance to actual names and addresses is purely coincidental. 16 Avery Dennison Investor Presentation